Skip to content

Clinical trials

Observational Narcolepsy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Narcolepsy Phase: Observational Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20091
20101
20111
20121
20151
20162
20171
20194
20203
20215
20224
20231
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting7
Unknown status4
Not yet recruiting1
Enrolling by invitation1
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospices Civils de Lyon4
Jazz Pharmaceuticals3
Assistance Publique - Hôpitaux de Paris1
Avadel1
Axsome Therapeutics, Inc.1
Boston Children's Hospital1
Brain Inflammation Collaborative1
Centre Hospitalier Universitaire de Saint Etienne1
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal1
Cephalon, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Narcolepsy32
Idiopathic Hypersomnia7
Disorders of Excessive Somnolence5
Cataplexy4
Sleep Apnea, Obstructive4
Anxiety Disorders2
Myasthenia Gravis2
REM Sleep Behavior Disorder2
Restless Legs Syndrome2
Sleep Initiation and Maintenance Disorders2

Trials

Showing 76 to 32 of 32. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.